Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Pristiq (in all its versions) list is 7
for a total market of 2.03Bln in 2016, and 1.05Bln year to date.

Seeing as how the FDA primarily approves drugs to increase competition thereby reducing costs... my guess is that Pristiq will be the next drug approved as there are only 7 competitors.

Ranexa (just one version) just 3
for a total market of 973Mln in 2016, and 802Mln year to date.

Has a generic version of Ranexa been approved?

No. There is currently no therapeutically equivalent version of Ranexa available in the United States.

Patent expiration dates: May 27, 2019 I think this will make decent money down the road... should be tentatively approved before May 2019.